CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.640
+0.240 (10.00%)
At close: Jun 6, 2025, 4:00 PM
2.650
+0.010 (0.38%)
After-hours: Jun 6, 2025, 6:59 PM EDT

CytomX Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
47.638.0517.17193.65205.53191.86
Upgrade
Short-Term Investments
32.2862.57157.34-99.7124.26
Upgrade
Cash & Short-Term Investments
79.89100.62174.51193.65305.23316.12
Upgrade
Cash Growth
-46.84%-42.34%-9.88%-36.55%-3.45%6.74%
Upgrade
Receivables
1.963.13.4335.990.790.8
Upgrade
Prepaid Expenses
4.793.5857.474.297.1
Upgrade
Total Current Assets
86.63107.31182.94237.1310.3324.01
Upgrade
Property, Plant & Equipment
9.2810.616.1821.0225.3229.45
Upgrade
Goodwill
0.950.950.950.950.950.95
Upgrade
Other Intangible Assets
0.550.580.730.881.021.17
Upgrade
Other Long-Term Assets
1.091.0910.941.823.09
Upgrade
Total Assets
98.5120.53201.79260.89339.41358.66
Upgrade
Accounts Payable
0.281.091.462.812.823
Upgrade
Accrued Expenses
10.5512.3417.622.8230.6219.86
Upgrade
Current Portion of Leases
5.295.154.594.083.623.2
Upgrade
Current Unearned Revenue
33.2367.2132.27121.2740.8242.06
Upgrade
Other Current Liabilities
0.86--1.63--
Upgrade
Total Current Liabilities
50.285.77155.91152.6177.8768.11
Upgrade
Long-Term Leases
2.864.249.3913.9818.0621.68
Upgrade
Long-Term Unearned Revenue
16.2126.8680.05180.06243.94276.65
Upgrade
Other Long-Term Liabilities
4.184.123.89---
Upgrade
Total Liabilities
73.45120.99249.24346.64339.87366.44
Upgrade
Common Stock
000000
Upgrade
Additional Paid-In Capital
693.1691.1675.91637.12623.34499.96
Upgrade
Retained Earnings
-668.05-691.58-723.45-722.88-623.56-507.69
Upgrade
Comprehensive Income & Other
-00.030.10.01-0.24-0.05
Upgrade
Total Common Equity
25.05-0.46-47.45-85.75-0.46-7.77
Upgrade
Shareholders' Equity
25.05-0.46-47.45-85.75-0.46-7.77
Upgrade
Total Liabilities & Equity
98.5120.53201.79260.89339.41358.66
Upgrade
Total Debt
8.159.3913.9718.0621.6724.87
Upgrade
Net Cash (Debt)
71.7491.24160.54175.59283.55291.25
Upgrade
Net Cash Growth
-47.79%-43.17%-8.58%-38.07%-2.64%8.49%
Upgrade
Net Cash Per Share
0.841.082.182.674.426.31
Upgrade
Filing Date Shares Outstanding
80.6280.167.7266.2365.3964.78
Upgrade
Total Common Shares Outstanding
80.6280.167.3166.2365.3948.25
Upgrade
Working Capital
36.4321.5327.0284.49232.43255.9
Upgrade
Book Value Per Share
0.31-0.01-0.70-1.29-0.01-0.16
Upgrade
Tangible Book Value
23.55-1.99-49.13-87.58-2.43-9.89
Upgrade
Tangible Book Value Per Share
0.29-0.02-0.73-1.32-0.04-0.20
Upgrade
Machinery
-16.6916.31717.7516.4
Upgrade
Construction In Progress
--0.370.710.310.25
Upgrade
Leasehold Improvements
-2.011.981.741.741.73
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q